SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study
NCT: NCT07116668 · ENROLLING_BY_INVITATION
Brief Summary
Colorectal cancer is the third most common malignancy worldwide and the second most common in the US. It is the second leading cause of cancer death worldwide, with 1.8 million new cases and 862,000 deaths per year. The majority of patients receive surgical treatment. Colorectal surgery is associated with a high risk of morbidity and mortality in comparison to other general surgery subspecialties. This study aims to further assess the safety and effectiveness of the Colovac Anastomosis Protection Device, a temporary intraluminal bypass device, on a larger scale.
Frequently Asked Questions
What is SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study?
SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study is a clinical trial registered under NCT07116668. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT07116668?
The current status of NCT07116668 (SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study) is: ENROLLING_BY_INVITATION.
When did SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study start?
SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study started on 2026-01-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.